# Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

> **NCT06597058** · PHASE2 · COMPLETED · sponsor: **Noah Pharmaceuticals, Inc.** · enrollment: 121 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** MAR

## Key facts

- **NCT ID:** NCT06597058
- **Lead sponsor:** Noah Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-16
- **Primary completion:** 2025-11-05
- **Final completion:** 2025-12-15
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06597058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06597058, "Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06597058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*